GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AnaptysBio Inc (STU:AN6) » Definitions » Purchase Of Investment

AnaptysBio (STU:AN6) Purchase Of Investment : €-290.56 Mil (TTM As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is AnaptysBio Purchase Of Investment?

AnaptysBio's purchase of investment for the three months ended in Mar. 2024 was €-54.28 Mil. It means AnaptysBio spent €54.28 Mil on purchasing investments. AnaptysBio's purchase of investment for the trailing twelve months (TTM) ended in Mar. 2024 was €-290.56 Mil.

Compared with last quarter (€-60.80 Mil in Dec. 2023 ), AnaptysBio spent less money on purchasing investments in Mar. 2024 (€-54.28 Mil).

AnaptysBio Purchase Of Investment Historical Data

The historical data trend for AnaptysBio's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AnaptysBio Purchase Of Investment Chart

AnaptysBio Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Purchase Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only -226.63 -160.23 -105.02 -757.56 -278.69

AnaptysBio Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Purchase Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -45.35 -109.85 -65.64 -60.80 -54.28

AnaptysBio Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-290.56 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AnaptysBio Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of AnaptysBio's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

AnaptysBio (STU:AN6) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AnaptysBio Inc (STU:AN6) » Definitions » Purchase Of Investment
Comparable Companies
ANTX EWTX ALEC DYN FDMT LYEL AVXL TSHA TARS ALLO OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
ANAB:USA
Address
10770 Wateridge Circle, Suite 210, San Diego, CA, USA, 92121
Website
https://www.anaptysbio.com
AnaptysBio Inc is a clinical-stage biotechnology company. It is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company develops product candidates to address emerging biological targets using its proprietary, antibody discovery technology platform, which is designed to replicate, in vitro, the natural process of antibody generation. Its product candidates are ANB020, ANB019, and Checkpoint receptor agonists. The entity generates revenue from collaborative research and development arrangements.

AnaptysBio (STU:AN6) Headlines

No Headlines